SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1998. Upgrade now.
Date Value
December 31, 2023 3.326B
September 30, 2023 2.907B
June 30, 2023 2.839B
March 31, 2023 2.605B
December 31, 2022 2.867B
September 30, 2022 2.420B
June 30, 2022 2.597B
March 31, 2022 2.431B
December 31, 2021 2.956B
September 30, 2021 2.315B
June 30, 2021 2.361B
March 31, 2021 3.346B
December 31, 2020 -1.131B
September 30, 2020 3.449B
June 30, 2020 3.359B
March 31, 2020 3.738B
December 31, 2019 4.435B
September 30, 2019 3.563B
June 30, 2019 3.329B
March 31, 2019 3.227B
December 31, 2018 3.371B
September 30, 2018 3.292B
June 30, 2018 3.348B
March 31, 2018 3.213B
December 31, 2017 3.364B
Date Value
September 30, 2017 3.021B
June 30, 2017 3.041B
March 31, 2017 3.037B
December 31, 2016 3.368B
September 30, 2016 3.011B
June 30, 2016 3.123B
March 31, 2016 3.134B
December 31, 2015 3.789B
September 30, 2015 3.050B
June 30, 2015 3.892B
March 31, 2015 3.373B
December 31, 2014 3.491B
September 30, 2014 3.361B
June 30, 2014 3.458B
March 31, 2014 3.261B
December 31, 2013 3.561B
September 30, 2013 3.076B
June 30, 2013 3.404B
March 31, 2013 3.231B
December 31, 2012 3.549B
September 30, 2012 3.531B
June 30, 2012 3.483B
March 31, 2012 3.365B
December 31, 2011 3.413B
September 30, 2011 3.241B

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

-1.131B
Minimum
Dec 2020
4.435B
Maximum
Dec 2019
2.827B
Average
2.907B
Median
Sep 2023

SG&A Expense (Quarterly) Benchmarks

AstraZeneca PLC 3.983B
Haleon PLC 1.357B
Novo Nordisk A/S 2.688B
Pfizer Inc 4.575B
Sanofi SA 3.156B